U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07763184) titled 'mNGS for IFD in Patients With Hematological Malignancies' on Aug. 02.
Brief Summary: Invasive fungal disease (IFD) refers to an infectious disease caused by fungi invading the human body, growing and reproducing in tissues, organs, or blood, and leading to inflammatory responses and tissue damage. Due to the suppression of immune system function during the disease and its treatment process, patients with hematological malignancies are prone to opportunistic infections, including IFD, with the lungs being the most common site of infection. In patients with hematological malignancies, IFD is often difficult to diagnose and progresses ...